Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.

"Declarations Ethics approval and consent to participateWe declare that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that all authors consent to participate in the writing of manuscript, and the order of authors listed in the manuscript has been approved by all of us. Consent for publicationAll authors approved the final version to be published. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (No. 82001740) and the National Social Science Fund of China (21BTQ050)."